バイオシミュレーションの世界市場分析:製品別(ソフトウェア、サービス、社内サービス、契約サービス)、用途別(薬の開発、薬の発見)、エンドユーザー別(医薬品・バイオテクノロジー企業、CRO、規制当局、学術研究機関)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Biosimulation Market Analysis By Product (Software, Services, In-house Services, Contract Services), By Application (Drug Development, Drug Discovery), By End-use (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions) And Segment Forecasts To 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
4.1. Market segmentation & scope
4.2. Market Driver Analysis
4.3. Market Restraint Analysis
4.4. Penetration & growth prospect mapping
4.5. Biosimulation – SWOT Analysis, By Factor (political & legal, economic and technological)
4.6. Industry Analysis – Porter’s
Chapter 5. Market Categorization 1: Product Estimates & Trend Analysis
5.1. Biosimulation market: Product movement analysis
5.2. Software
5.2.1. Software Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.3. Services
5.3.1. Services Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.3.2. In-house Services
5.3.2.1. In-house Services Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.3.3. Contract Services
5.3.3.1. Contract Services Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 6. Market Categorization 2: Application Estimates & Trend Analysis
6.1. Biosimulation market: Application movement analysis
6.2. Drug Development
6.2.1. Drug Development Market Estimates and Forecasts, 2013 – 2024 (USD Million)
6.3. Drug Discovery
6.3.1. Drug Discovery Market Estimates and Forecasts, 2013 – 2024 (USD Million)
6.4. Others
6.4.1. Others Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 7. Market Categorization 3: End-use Estimates & Trend Analysis
7.1. Biosimulation market: Application movement analysis
7.2. Pharmaceutical & Biotechnology Companies
7.2.1. Pharmaceutical &Biotechnology Companies Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.3. CROs
7.3.1. CROs Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.4. Regulatory Authorities
7.4.1. Regulatory Authorities Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.5. Academic Research Institutions
7.5.1. Academic Research Institutions Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 8. Market Categorization 3: Regional Estimates & Trend Analysis, By Type & Application
8.1. Biosimulation Market Share by Region, 2015 & 2024
8.2. North America
8.2.1. North America Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.2.1.1. U.S. Market Estimates and Forecasts
8.2.1.2. Canada Market Estimates and Forecasts
8.2.2. North America Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.2.2.1. U.S. Market Estimates and Forecasts
8.2.2.2. Canada Market Estimates and Forecasts
8.2.3. North America Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.2.3.1. U.S. Market Estimates and Forecasts
8.2.3.2. Canada Market Estimates and Forecasts
8.3. Europe
8.3.1. Europe Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.3.1.1. UK Market Estimates and Forecasts
8.3.1.2. Germany Market Estimates and Forecasts
8.3.2. Europe Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.3.2.1. UK Market Estimates and Forecasts
8.3.2.2. Germany Market Estimates and Forecasts
8.3.3. Europe Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.3.3.1. UK Market Estimates and Forecasts
8.3.3.2. Germany Market Estimates and Forecasts
8.4. Asia Pacific
8.4.1. Asia Pacific Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.4.1.1. Japan Market Estimates and Forecasts
8.4.1.2. China Market Estimates and Forecasts
8.4.1.3. India Market Estimates and Forecasts
8.4.2. Asia Pacific Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.4.2.1. Japan Market Estimates and Forecasts
8.4.2.2. China Market Estimates and Forecasts
8.4.2.3. India Market Estimates and Forecasts
8.4.3. Asia Pacific Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.4.3.1. Japan Market Estimates and Forecasts
8.4.3.2. China Market Estimates and Forecasts
8.4.3.3. India Market Estimates and Forecasts
8.5. Latin America
8.5.1. Latin America Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.5.1.1. Brazil Market Estimates and Forecasts
8.5.1.2. Mexico Market Estimates and Forecasts
8.5.2. Latin America Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.5.2.1. Brazil Market Estimates and Forecasts
8.5.2.2. Mexico Market Estimates and Forecasts
8.5.3. Latin America Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.5.3.1. Brazil Market Estimates and Forecasts
8.5.3.2. Mexico Market Estimates and Forecasts
8.6. MEA
8.6.1. MEA Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.6.1.1. South Africa Market Estimates and Forecasts
8.6.2. MEA Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.6.2.1. South Africa Market Estimates and Forecasts
8.6.3. MEA Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.6.3.1. South Africa Market Estimates and Forecasts
Chapter 9. Competitive Landscape
9.1. Strategy framework
9.2. Market participation categorization
9.3. Company Profiles
9.3.1. Certara USA, Inc.
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Simulation Plus, Inc.
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Dassault Systems SA
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Schrodinger, Inc.
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Advanced Chemistry Development, Inc.
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Chemical Computing Group, Inc.
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Physiomics PLC
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Entelos, Inc.
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Rhenovia Pharma Ltd.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Genedata AG
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Leadscope, Inc.
9.3.11.1. Company Overview
9.3.11.2. Financial Performance
9.3.11.3. Product Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. Evidera, Inc.
9.3.12.1. Company Overview
9.3.12.2. Financial Performance
9.3.12.3. Product Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. Insilico Biotechnology AG
9.3.13.1. Company Overview
9.3.13.2. Financial Performance
9.3.13.3. Product Benchmarking
9.3.13.4. Strategic Initiatives
9.3.14. LeadInvent Technologies Pvt. Ltd.
9.3.14.1. Company Overview
9.3.14.2. Financial Performance
9.3.14.3. Product Benchmarking
9.3.14.4. Strategic Initiatives
9.3.15. InhibOx Ltd.
9.3.15.1. Company Overview
9.3.15.2. Financial Performance
9.3.15.3. Product Benchmarking
9.3.15.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:バイオシミュレーションの世界市場分析:製品別(ソフトウェア、サービス、社内サービス、契約サービス)、用途別(薬の開発、薬の発見)、エンドユーザー別(医薬品・バイオテクノロジー企業、CRO、規制当局、学術研究機関)、セグメント予測
■ 英文:Biosimulation Market Analysis By Product (Software, Services, In-house Services, Contract Services), By Application (Drug Development, Drug Discovery), By End-use (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions) And Segment Forecasts To 2024
■ 発行日:2016年8月21日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707129
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。